CLINICAL_TRIALS
trial_result
· 2020-10-06
Clinical Trial Update: Exjade-Early-Trial [Phase 2]
Summary
Phase 2 clinical trial update for Exjade in myelodysplastic syndromes; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Myelodysplastic Syndromes | Phase 2 | Status: TERMINATED | Results posted: 2020-10-06